Bio-Techne Announces New Customer Experience Centre in D眉sseldorf, Germany
Bio-Techne (NASDAQ: TECH) has announced plans to open a new Customer Experience Centre in D眉sseldorf, Germany by summer 2026, aimed at serving the EMEA (Europe, Middle East and Africa) region. The facility will feature a state-of-the-art Demonstration Laboratory showcasing the company's complete instrument portfolio.
Key highlights include the newly launched Leo鈩� System with Simple Western鈩� Technology for automated western blot assays, and the 颁翱惭贰罢鈩� spatial biology platform for automated, high-throughput tissue profiling. The center will complement Bio-Techne's existing UK facility, allowing for expanded customer demonstrations and hands-on experience with their instruments.
The strategic location in D眉sseldorf was selected for its vibrant life sciences sector and proximity to the Benelux region, facilitating access to multiple European markets. This expansion will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, particularly in the German market.
Bio-Techne (NASDAQ: TECH) ha annunciato piani per aprire un nuovo Centro Esperienza Clienti a D眉sseldorf, Germania entro l'estate del 2026, con l'obiettivo di servire la regione EMEA (Europa, Medio Oriente e Africa). La struttura presenter脿 un laboratorio dimostrativo all'avanguardia che mostrer脿 l'intero portafoglio di strumenti dell'azienda.
I punti salienti includono il nuovo Leo鈩� System con tecnologia Simple Western鈩� per saggi di western blot automatizzati, e la piattaforma di biologia spaziale 颁翱惭贰罢鈩� per il profiling tissutale automatizzato e ad alta capacit脿. Il centro completer脿 la struttura esistente di Bio-Techne nel Regno Unito, consentendo dimostrazioni pi霉 ampie per i clienti e un'esperienza pratica con i loro strumenti.
La posizione strategica a D眉sseldorf 猫 stata scelta per il suo vivace settore delle scienze della vita e la vicinanza alla regione Benelux, facilitando l'accesso a diversi mercati europei. Questa espansione permetter脿 a Bio-Techne di crescere il proprio team a contatto con i clienti in EMEA e supportare la crescita regionale a lungo termine, in particolare nel mercato tedesco.
Bio-Techne (NASDAQ: TECH) ha anunciado planes para abrir un nuevo Centro de Experiencia del Cliente en D眉sseldorf, Alemania para el verano de 2026, con el objetivo de atender la regi贸n EMEA (Europa, Medio Oriente y 脕frica). La instalaci贸n contar谩 con un laboratorio de demostraci贸n de 煤ltima generaci贸n que mostrar谩 todo el portafolio de instrumentos de la compa帽铆a.
Los aspectos m谩s destacados incluyen el reci茅n lanzado Leo鈩� System con tecnolog铆a Simple Western鈩� para ensayos de western blot automatizados, y la plataforma de biolog铆a espacial 颁翱惭贰罢鈩� para el perfilado de tejidos automatizado y de alto rendimiento. El centro complementar谩 la instalaci贸n existente de Bio-Techne en el Reino Unido, permitiendo demostraciones ampliadas para los clientes y experiencia pr谩ctica con sus instrumentos.
La ubicaci贸n estrat茅gica en D眉sseldorf fue seleccionada por su vibrante sector de ciencias de la vida y su proximidad a la regi贸n de Benelux, facilitando el acceso a m煤ltiples mercados europeos. Esta expansi贸n permitir谩 a Bio-Techne hacer crecer su equipo de atenci贸n al cliente en EMEA y apoyar el crecimiento regional a largo plazo, especialmente en el mercado alem谩n.
Bio-Techne (NASDAQ: TECH)電� 2026雲� 鞐旯岇 霃呾澕 霋れ厐霃勲ゴ頂�鞐� 靸堧鞖� 瓿犼皾 瓴巾棙 靹柬劙毳� 鞐� 瓿勴殟鞚� 氚滍憸頄堨姷雼堧嫟. 鞚� 靹柬劙電� EMEA(鞙犽熃, 欷戨彊 氚� 鞎勴攧毽勾) 歆�鞐潉 雽�靸侅溂搿� 頃╇媹雼�. 鞚� 鞁滌劋鞚� 須岇偓鞚� 鞝勳泊 旮瓣赴 韽姼韽措Μ鞓るゼ 靹犽炒鞚措姅 斓滌波雼� 鞁滌棸 鞁ろ棙鞁れ潉 臧栰稖 鞓堨爼鞛呺媹雼�.
欤检殧 頃橃澊霛检澊韸鸽電� 鞛愲彊頇旊悳 鞗姢韯� 敫旊’ 攵勳劃鞚� 鞙勴暅 Simple Western鈩� 旮办垹鞚� 臧栰稑 鞁犾牅頀� Leo鈩� System瓿� 鞛愲彊頇旊悳 瓿犾矘毽焿 臁办 頂勲韺岇澕毵侅潉 鞙勴暅 颁翱惭贰罢鈩� 瓿店皠 靸濍頃� 頂岆灚韽检澊 鞛堨姷雼堧嫟. 鞚� 靹柬劙電� Bio-Techne鞚� 旮办〈 鞓侁淡 鞁滌劋鞚� 氤挫檮頃橃棳 瓿犼皾鞚� 鞙勴暅 雿� 毵庫潃 鞁滌棸瓿� 旮瓣赴 靷毄 瓴巾棙鞚� 鞝滉车頃� 瓴冹瀰雼堧嫟.
霋れ厐霃勲ゴ頂勳潣 鞝勲灥鞝� 鞙勳箻電� 頇滉赴彀� 靸濍獏 瓿柬暀 攵�氍戈臣 氩赴鞐�, 雱る崪霝�霌�, 耄╈厛攵�毳错伂(Benelux) 歆�鞐臣鞚� 攴检爲靹� 雿曤秳鞐� 靹犿儩霅橃棃鞀惦媹雼�. 鞚措姅 鞐煬 鞙犽熃 鞁滌灔鞐� 鞝戧芳頃� 靾� 鞛堧弰搿� 頃╇媹雼�. 鞚� 頇曥灔鞚� Bio-Techne臧� EMEA鞐愳劀 瓿犼皾 雽�鞚� 韺�鞚� 頇曥灔頃橁碃 霃呾澕 鞁滌灔鞐愳劀鞚� 鞛リ赴鞝侅澑 歆�鞐� 靹膘灔 歆�鞗愳潉 臧�電ロ晿瓴� 頃� 瓴冹瀰雼堧嫟.
Bio-Techne (NASDAQ: TECH) a annonc茅 son intention d'ouvrir un nouveau Centre d'Exp茅rience Client 脿 D眉sseldorf, Allemagne, d'ici l'茅t茅 2026, afin de servir la r茅gion EMEA (Europe, Moyen-Orient et Afrique). L'茅tablissement comprendra un laboratoire de d茅monstration 脿 la pointe de la technologie, mettant en avant l'ensemble du portefeuille d'instruments de l'entreprise.
Les points forts incluent le nouveau Leo鈩� System avec la technologie Simple Western鈩� pour des essais de western blot automatis茅s, ainsi que la plateforme de biologie spatiale 颁翱惭贰罢鈩� pour le profilage tissulaire automatis茅 et 脿 haut d茅bit. Le centre compl茅tera l'茅tablissement existant de Bio-Techne au Royaume-Uni, permettant des d茅monstrations clients 茅largies et une exp茅rience pratique avec leurs instruments.
La localisation strat茅gique 脿 D眉sseldorf a 茅t茅 choisie en raison de son secteur dynamique des sciences de la vie et de sa proximit茅 avec la r茅gion Benelux, facilitant l'acc猫s 脿 plusieurs march茅s europ茅ens. Cette expansion permettra 脿 Bio-Techne de d茅velopper son 茅quipe d茅di茅e aux clients dans la r茅gion EMEA et de soutenir la croissance r茅gionale 脿 long terme, en particulier sur le march茅 allemand.
Bio-Techne (NASDAQ: TECH) hat Pl盲ne angek眉ndigt, bis zum Sommer 2026 ein neues Kundenerlebniszentrum in D眉sseldorf, Deutschland, zu er枚ffnen, das darauf abzielt, die EMEA-Region (Europa, Naher Osten und Afrika) zu bedienen. Die Einrichtung wird ein modernes Demonstrationslabor umfassen, das das gesamte Instrumentenportfolio des Unternehmens pr盲sentiert.
Zu den wichtigsten Highlights geh枚rt das neu eingef眉hrte Leo鈩� System mit der Simple Western鈩�-Technologie f眉r automatisierte Western-Blot-Assays sowie die 颁翱惭贰罢鈩�-Plattform f眉r r盲umliche Biologie zur automatisierten, hochdurchsatzf盲higen Gewebeprofilierung. Das Zentrum wird die bestehende Einrichtung von Bio-Techne im Vereinigten K枚nigreich erg盲nzen und erweiterte Kundendemonstrationen sowie praktische Erfahrungen mit ihren Instrumenten erm枚glichen.
Der strategische Standort in D眉sseldorf wurde aufgrund seines dynamischen Lebenswissenschaftssektors und der N盲he zur Benelux-Region ausgew盲hlt, was den Zugang zu mehreren europ盲ischen M盲rkten erleichtert. Diese Expansion wird es Bio-Techne erm枚glichen, sein kundenorientiertes Team in der EMEA zu vergr枚脽ern und das langfristige regionale Wachstum, insbesondere im deutschen Markt, zu unterst眉tzen.
- Strategic expansion into key European market with new demonstration facility
- Potential for increased market penetration in EMEA region
- Enhanced customer support and demonstration capabilities
- None.
The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art Demonstration Laboratory hosting Bio-Techne's full instrument portfolio, including:
- The recently launched Leo鈩� System, powered by Simple Western鈩� Technology, which offers the throughput and precision of standard ELISAs in a fully automated western blot assay, expanding applications in bioanalytical workflows from discovery through commercialization.
- The best-in-class spatial biology platform, 颁翱惭贰罢鈩�, which is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities.
"Our new Customer Experience Centre will complement our existing Demonstration Laboratory in the
The facility's capacity will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, including in the large German market.
D眉sseldorf was carefully chosen as the site for this new centre due to its thriving life sciences sector and strategic proximity to the Benelux region, providing seamless access to customers from multiple European markets.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
听(狈础厂顿础蚕: TECH)
Contact: David听Clair, Vice President, Investor Relations & Corporate Development
[email protected]听
612-656-4416
View original content to download multimedia:
SOURCE Bio-Techne Corporation
FAQ
When will Bio-Techne (TECH) open its new Customer Experience Centre in D眉sseldorf?
What key instruments will Bio-Techne (TECH) showcase at the D眉sseldorf facility?
Why did Bio-Techne (TECH) choose D眉sseldorf for its new Customer Experience Centre?
How will the new D眉sseldorf facility impact Bio-Techne's (TECH) EMEA operations?
